Animesh D Pardanani, MBBS, PhD

  • 19491 Citations
  • 77 Scopus h-Index
1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1993 2020

Filter
Article
2019
5 Citations (Scopus)

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Szuber, N., Mudireddy, M., Nicolosi, M., Penna, D., Vallapureddy, R. R., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Hook, C. C., Wolanskyj, A. P., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Sirhan, S., Pardanani, A. D., Gangat, N., Busque, L. & Tefferi, A., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalArticle

Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Survival
Neoplasms

Calculator-free point-of-care prognostication in myelodysplastic syndromes

Tefferi, A., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Point-of-Care Systems
Myelodysplastic Syndromes

Essential thrombocythemia

Tefferi, A. & Pardanani, A., Nov 28 2019, In : New England Journal of Medicine. 381, 22, p. 2135-2144 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Etiologies of Extreme Thrombocytosis: A Contemporary Series

Hsieh, R. W., Ravindran, A., Hook, C. C., Begna, K., Ashrani, A. A., Pruthi, R. K., Marshall, A. L., Hogan, W., Litzow, M. R., Hoyer, J., Oliveira, J., Vishnu, P., Call, T. G., Al-Kali, A., Patnaik, M. M., Gangat, N., Pardanani, A. D., Tefferi, A. & Go, R. S., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1542-1550 9 p.

Research output: Contribution to journalArticle

Thrombocytosis
Hematologic Neoplasms
Outpatients
Inpatients
Splenectomy

Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model

Vallapureddy, R. R., Mudireddy, M., Penna, D., Lasho, T. L., Finke, C. M., Hanson, C. A., Ketterling, R. P., Begna, K., Gangat, N., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 12.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Anemia
Incidence
Karyotype
8 Citations (Scopus)

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

Coston, T., Pophali, P., Vallapureddy, R., Lasho, T. L., Finke, C. M., Ketterling, R. P., Carr, R., Binder, M., Mangaonkar, A. A., Gangat, N., Al-Kali, A., Litzow, M. R., Zblewski, D., Pardanani, A. D., Tefferi, A. & Patnaik, M. M., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
decitabine
Survival
Therapeutics
2018

20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients

Penna, D., Lasho, T. L., Finke, C. M., Vallapureddy, R. R., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Survival
Platelet Count
Leukocyte Count
Genetic Markers
10 Citations (Scopus)

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

Patnaik, M. M., Rangit Vallapureddy, V., Lasho, T. L., Hoversten, K. P., Finke, C. M., Ketterling, R. P., Hanson, C. A., Gangat, N., Tefferi, A. & Pardanani, A. D., Apr 2 2018, (Accepted/In press) In : Leukemia. p. 1-6 6 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Systemic Mastocytosis
1 Citation (Scopus)

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

Begna, K., Ali, W., Gangat, N., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W., Patnaik, M. M., Pardanani, A. D., Zblewski, D. L., Chen, D., He, R., Viswanatha, D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Karyotype
Acute Myeloid Leukemia
2 Citations (Scopus)

A test utilization approach to the diagnostic workup of isolated eosinophilia in otherwise morphologically unremarkable bone marrow: A single institutional experience

Fang, H., Ketterling, R. P., Hanson, C. A., Pardanani, A. D., Kurtin, P. J., Chen, D., Greipp, P. T., Howard, M. T., King, R., Van Dyke, D. L. & Reichard, K. K., Oct 1 2018, In : American Journal of Clinical Pathology. 150, 5, p. 421-431 11 p.

Research output: Contribution to journalArticle

Eosinophilia
Bone Marrow
Platelet-Derived Growth Factor beta Receptor
Systemic Mastocytosis
Hypereosinophilic Syndrome
16 Citations (Scopus)

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts

Tefferi, A., Mudireddy, M., Mannelli, F., Begna, K., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Gangat, N., Yogarajah, M., de Stefano, V., Passamonti, F., Rosti, V., Finazzi, M. C., Rambaldi, A., Bosi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Feb 2 2018, (Accepted/In press) In : Leukemia. p. 1-11 11 p.

Research output: Contribution to journalArticle

Blast Crisis
Stem Cells
Transplants
Survival
Neoplasms
3 Citations (Scopus)

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

Shah, S., Pardanani, A. D., Elala, Y. C., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Chromosome Aberrations
Incidence
Abnormal Karyotype
Mast-Cell Leukemia

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

Tefferi, A., Szuber, N., Vallapureddy, R. R., Begna, K., Patnaik, M. M., Elliott, M. A., Christopher Hook, C., Wolanskyj, A. P., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Survival Rate
Primary Myelofibrosis
Survival
Busulfan

Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis

Szuber, N., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Calreticulin
Primary Myelofibrosis
2 Citations (Scopus)

Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

Tefferi, A., Nicolosi, M., Penna, D., Mudireddy, M., Szuber, N., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Aug 14 2018, In : Blood Advances. 2, 15, p. 1980-1984 5 p.

Research output: Contribution to journalArticle

Open Access
Primary Myelofibrosis
Cachexia
Serum Albumin
Cholesterol
2 Citations (Scopus)

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis

Mudireddy, M., Gangat, N., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Ashrani, A. A., Pardanani, A. D., Nagorney, D. M. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Splenectomy
5 Citations (Scopus)

Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience

Oliveira, J., Coon, L. M., Frederick, L. A., Hein, M., Swanson, K. C., Savedra, M. E., Porter, T. R., Patnaik, M. M., Tefferi, A., Pardanani, A. D., Grebe, S. K., Viswanatha, D. S. & Hoyer, J., Aug 1 2018, In : American Journal of Hematology. 93, 8, p. 1029-1041 13 p.

Research output: Contribution to journalArticle

Hemoglobins
Mutation
Oxygen
2,3-Diphosphoglycerate
Restless Legs Syndrome
32 Citations (Scopus)

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

Tefferi, A., Guglielmelli, P., Nicolosi, M., Mannelli, F., Mudireddy, M., Bartalucci, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Begna, K., Naseema Gangat, G., Pardanani, A. D. & Vannucchi, A. M., Mar 23 2018, (Accepted/In press) In : Leukemia. p. 1-12 12 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Karyotype
Survival
Genetic Markers
5 Citations (Scopus)

How I treat myelofibrosis after failure of JAK inhibitors

Pardanani, A. D. & Tefferi, A., Aug 2 2018, In : Blood. 132, 5, p. 492-500 9 p.

Research output: Contribution to journalArticle

Transplants
Primary Myelofibrosis
Patient treatment
Investigational Drugs
Salvaging
12 Citations (Scopus)

Mast cell activation syndrome: Importance of consensus criteria and call for research

Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Broesby-Olsen, S., Brockow, K., Butterfield, J. H., Reiter, A., Gotlib, J., Castells, M., Milner, J. D., Carter, M. C., Komarow, H., Radia, D., Pardanani, A. D., Sotlar, K., Triggiani, M., Horny, H. P., Arock, M., Schwartz, L. B. & 1 others, Metcalfe, D. D., Jan 1 2018, (Accepted/In press) In : Journal of Allergy and Clinical Immunology.

Research output: Contribution to journalArticle

Mast Cells
Research
6 Citations (Scopus)

Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information

Tefferi, A., Gangat, N., Mudireddy, M., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W., Patnaik, M. M., Pardanani, A. D., Zblewski, D. L., He, R., Viswanatha, D., Hanson, C. A., Ketterling, R. P., Tang, J. L. & 5 others, Chou, W. C., Lin, C. C., Tsai, C. H., Tien, H. F. & Hou, H. A., Jan 1 2018, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Taiwan
Karyotype
Mutation
Area Under Curve
9 Citations (Scopus)

Mayo alliance prognostic system for mastocytosis: Clinical and hybrid clinical-molecular models

Pardanani, A., Shah, S., Mannelli, F., Elala, Y. C., Guglielmelli, P., Lasho, T. L., Patnaik, M. M., Gangat, N., Ketterling, R. P., Reichard, K. K., Hanson, C. A., Vannucchi, A. M. & Tefferi, A., Nov 13 2018, In : Blood Advances. 2, 21, p. 2964-2972 9 p.

Research output: Contribution to journalArticle

Open Access
Systemic Mastocytosis
Mastocytosis
Molecular Models
Confidence Intervals
Mutation
3 Citations (Scopus)

Mayo CALR mutation type classification guide using alpha helix propensity

Lasho, T. L., Finke, C. M., Tischer, A., Pardanani, A. D. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Mutation
alpha-Helical Protein Conformation
87 Citations (Scopus)

MIPSS70: Mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis

Guglielmelli, P., Lasho, T. L., Rotunno, G., Mudireddy, M., Mannarelli, C., Nicolosi, M., Pacilli, A., Pardanani, A. D., Rumi, E., Rosti, V., Hanson, C. A., Mannelli, F., Ketterling, R. P., Gangat, N., Rambaldi, A., Passamonti, F., Barosi, G., Barbui, T., Cazzola, M., Vannucchi, A. M. & 1 others, Tefferi, A., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, p. 310-318 9 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Transplantation
Mutation
Cytogenetics
Survival
5 Citations (Scopus)

Momelotinib therapy for myelofibrosis: A 7-year follow-up

Tefferi, A., Barraco, D., Lasho, T. L., Shah, S., Begna, K., Al-Kali, A., Hogan, W., Litzow, M. R., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Mar 1 2018, In : Blood Cancer Journal. 8, 3, 29.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Karyotype
Mutation
Survival
Peripheral Nervous System Diseases
8 Citations (Scopus)

Mutations and karyotype predict treatment response in myelodysplastic syndromes

Idossa, D., Lasho, T. L., Finke, C. M., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Karyotype
Mutation
Therapeutics
Hematinics
15 Citations (Scopus)

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

Gangat, N., Mudireddy, M., Lasho, T. L., Finke, C. M., Nicolosi, M., Szuber, N., Patnaik, M. M., Pardanani, A. D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Genetic Models
Myelodysplastic Syndromes
Karyotype
Mutation
Survival

Mutations and prognosis in myeloproliferative neoplasms

Tefferi, A. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Mutation
Neoplasms
7 Citations (Scopus)

Myelofibrosis Treatment Algorithm 2018

Tefferi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 72.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Cytogenetics
Mutation
Transplants
Therapeutics
8 Citations (Scopus)

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

Szuber, N., Vallapureddy, R. R., Penna, D., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Neoplasms
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Cytogenetics

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

Tefferi, A., Shah, S., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Hematologic Neoplasms

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

Ogden, J., Yui, J., Ali, W., Mudireddy, M., Al-Kali, A., Patnaik, M. M., Gangat, N., Elliott, M., Hogan, W., Hook, C., Wolanskyj-Spinner, A., Pardanani, A. D., Vilarraga, H. R., Litzow, M. R., Tefferi, A. & Begna, K., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Anthracyclines
Acute Myeloid Leukemia
29 Citations (Scopus)

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients

Tefferi, A., Nicolosi, M., Mudireddy, M., Lasho, T. L., Gangat, N., Begna, K., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Feb 2 2018, (Accepted/In press) In : Leukemia. p. 1-11 11 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Cytogenetics
Survival
Mutation
Sex Chromosome Aberrations
2 Citations (Scopus)

Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome

Benton, C. B., Chien, K. S., Tefferi, A., Rodriguez, J., Ravandi, F., Daver, N., Jabbour, E., Jain, N., Alvarado, Y., Kwari, M., Pierce, S., Maiti, A., Hornbaker, M., Santos, M. A., Martinez, S., Siguero, M., Zblewski, D., Al-Kali, A., Hogan, W., Kantarjian, H. & 2 others, Pardanani, A. D. & Garcia-Manero, G., Jan 1 2018, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Safety
Appointments and Schedules
trabectedin
8 Citations (Scopus)

Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients

Nicolosi, M., Mudireddy, M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N., Pardanani, A. D. & Tefferi, A., Jan 30 2018, (Accepted/In press) In : Leukemia. p. 1-5 5 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Anemia
4 Citations (Scopus)

Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis

Tefferi, A., Shah, S., Reichard, K. K., Hanson, C. A. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Mastocytosis
2 Citations (Scopus)

Systemic mastocytosis, version 2.2019 clinical practice guidelines in oncology

Gotlib, J., Gerds, A. T., Bose, P., Castells, M. C., Deininger, M. W., Gojo, I., Gundabolu, K., Hobbs, G., Jamieson, C., McMahon, B., Mohan, S. R., Oehler, V., Oh, S., Padron, E., Pancari, P., Papadantonakis, N., Pardanani, A. D., Podoltsev, N., Rampal, R., Ranheim, E. & 9 others, Rein, L., Snyder, D. S., Stein, B. L., Talpaz, M., Thota, S., Wadleigh, M., Walsh, K., Bergman, M. A. & Sundar, H., Dec 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 12, p. 1500-1537 38 p.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Practice Guidelines
Mastocytosis
Mast Cells
Skin
8 Citations (Scopus)
Systemic Mastocytosis
Risk Management
Mast Cells
4'-N-benzoylstaurosporine
Mutation
15 Citations (Scopus)

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms

Lasho, T. L., Mudireddy, M., Finke, C. M., Hanson, C. A., Ketterling, R. P., Szuber, N., Begna, K., Patnaik, M. M., Gangat, N., Pardanani, A. D. & Tefferi, A., Feb 27 2018, In : Blood advances. 2, 4, p. 370-380 11 p.

Research output: Contribution to journalArticle

Open Access
Blast Crisis
Mutation
Neoplasms
Confidence Intervals
Essential Thrombocythemia
2 Citations (Scopus)

The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis

Tefferi, A., Lasho, T. L., Mudireddy, M., Finke, C. M., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Haplotypes
Survival
Mutation
Mutation Rate
1 Citation (Scopus)

The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes

Penna, D., Nicolosi, M., Vallapureddy, R. R., Szuber, N., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Anemia
Phenotype
13 Citations (Scopus)

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

Tefferi, A., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Feb 27 2018, (Accepted/In press) In : Leukemia. p. 1-4 4 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
3 Citations (Scopus)

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates

Tefferi, A., Mudireddy, M., Finke, C. M., Nicolosi, M., Lasho, T. L., Hanson, C. A., Patnaik, M. M., Pardanani, A. D. & Gangat, N., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Mutation
2017
1 Citation (Scopus)

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey

Begna, K., Al-Kali, A., Elliott, M., Foran, J. M., Gangat, N., Hogan, W., Hook, C., Leis, J., Litzow, M. R., Mesa, R., Palmer, J., Pardanani, A. D., Patnaik, M. M., Rivera, C. E., Sproat, L., Tibes, R., Wolanskyj-Spinner, A. & Tefferi, A., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

25 Citations (Scopus)

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis

Gilles, L., Arslan, A. D., Marinaccio, C., Wen, Q. J., Arya, P., McNulty, M., Yang, Q., Zhao, J. C., Konstantinoff, K., Lasho, T., Pardanani, A. D., Stein, B., Plo, I., Sundaravel, S., Wickrema, A., Migliaccio, A., Gurbuxani, S., Vainchenker, W., Platanias, L. C., Tefferi, A. & 1 others, Crispino, J. D., Apr 3 2017, In : Journal of Clinical Investigation. 127, 4, p. 1316-1320 5 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Megakaryocytes
Hematopoiesis
Down-Regulation
Extramedullary Hematopoiesis
22 Citations (Scopus)

Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients

Tefferi, A., Nicolosi, M., Mudireddy, M., Szuber, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N., Mannarelli, C., Fanelli, T., Guglielmelli, P. & Vannucchi, A. M., Jan 1 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Calreticulin
Primary Myelofibrosis
Mutation
Survival
Leukemia
7 Citations (Scopus)

Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients

Tefferi, A., Betti, S., Barraco, D., Mudireddy, M., Shah, S., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N., Coltro, G., Guglielmelli, P. & Vannucchi, A. M., Nov 1 2017, In : American Journal of Hematology. 92, 11, p. 1193-1197 5 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Survival
Thrombosis
Leukocyte Count
Italy
13 Citations (Scopus)

Monocytosis in polycythemia vera: Clinical and molecular correlates

Barraco, D., Cerquozzi, S., Gangat, N., Patnaik, M. M., Lasho, T., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Tefferi, A., Jul 1 2017, In : American Journal of Hematology. 92, 7, p. 640-645 6 p.

Research output: Contribution to journalArticle

Polycythemia Vera
Leukemia, Myelomonocytic, Chronic
Leukocytosis
Primary Myelofibrosis
Mutation
8 Citations (Scopus)

Prefibrotic versus overtly fibrotic primary myelofibrosis: Clinical, cytogenetic, molecular and prognostic comparisons

Mudireddy, M., Shah, S., Lasho, T., Barraco, D., Hanson, C. A., Ketterling, R. P., Gangat, N., Pardanani, A. D. & Tefferi, A., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Cytogenetics
12 Citations (Scopus)

Prognostic impact of bone marrow fibrosis in polycythemia vera: Validation of the IWG-MRT study and additional observations

Barraco, D., Cerquozzi, S., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Mar 10 2017, In : Blood Cancer Journal. 7, 3, e538.

Research output: Contribution to journalArticle

Polycythemia Vera
Primary Myelofibrosis
Reticulin
Splenomegaly
Leukocytosis